FFO
TECX icon

Fortitude Family Office’s Tectonic Therapeutic TECX Stock Holding History

Fortitude Family Office’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15
Closed -$464 – 2397
2026
Q1 		$464 Buy
+15
New +$369 ﹤0.01% 1758

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Fortitude Family Office's TECX Position: Q2 2026 in Review

Fortitude Family Office sold out of Tectonic Therapeutic (TECX) in Q2 2026, closing a stake of 15 shares — an estimated $464 sold.

Fortitude Family Office first reported a position in TECX in Q1 2026 and held it in 1 quarter. The position peaked at $464 in Q1 2026. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Fortitude Family Office reported no remaining Tectonic Therapeutic position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 15 Tectonic Therapeutic shares in Q2 2026, an estimated $464.
  • Fortitude Family Office first reported a position in Tectonic Therapeutic in Q1 2026 and held it in 1 quarter.
  • Fortitude Family Office's Tectonic Therapeutic position peaked at $464 in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.